Robert D. Hardie is 10% Owner at Acumen Pharmaceuticals, Inc. (ABOS). They have made 2 open-market trades across 1 company since 2021, most recently 2021-07-06.
CIK 0001804350
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $17.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABOS | 3,040,193 | $5.1M |
Shares reported on the most recent Form 4, priced at the 2021-07-08 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.